(Q38031619)
Statements
1 reference
Regulatory aspects of Phase 3 endpoints for new inhaled antibiotics for cystic fibrosis patients with chronic Pseudomonas aeruginosa infections (English)
1 reference
Alan Bruce Montgomery
1 reference
Tammy Abuan
1 reference
Melissa A Yeager
1 reference
1 August 2012
1 reference
1 reference
25
1 reference
4
1 reference
198-203
1 reference
Identifiers
1 reference
1 reference